missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human TH1L (aa 113-192) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (100%), Rat (100%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-65631 (PA5-65631. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The NELF complex of proteins interacts with the DSIF protein complex to repress transcriptional elongation by RNA polymerase II. The protein encoded by this gene is an essential part of the NELF complex. Alternative translation initiation site usage results in the formation of two isoforms with different N-termini.
Specifications
Specifications
| Accession Number | Q8IXH7 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 51497 |
| Name | Human TH1L (aa 113-192) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2410003I03Rik; C77797; HSPC130; Negative elongation factor C/D; negative elongation factor complex member C/D; negative elongation factor complex member C/D, Th1l; negative elongation factor complex member C/D,Th1l; negative elongation factor D; negative elongation factor D-like; negative elongation factor proteins C and D; NELF-C; NELF-C/D; NELFCD; Nelfd; NELF-D; TH1; TH1 drosophila homolog; TH1 homolog; TH1L; TH1-like; TH1-like homolog; TH1-like protein; trihydrophobin 1; trihydrophobin 1 homolog; zgc:55482 |
| Common Name | TH1L |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction